{"brief_title": "MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis", "brief_summary": "This study will compare the efficacy and safety of different treatment regimens of oral Bonviva tablets in women with post-menopausal osteoporosis. Patients will also receive daily supplementation with vitamin D and calcium. The anticipated time of study treatment is 2+ years, and the target sample size is 500+ individuals.", "condition": "Post Menopausal Osteoporosis", "intervention_type": "Dietary Supplement", "intervention_name": "Vitamin D", "description": "400 IU/day", "arm_group_label": "Ibandronate 150 mg", "criteria": "Inclusion Criteria: - women 55-80 years of age; - post-menopausal for >= 5 years; - ambulatory. Exclusion Criteria: - malignant disease diagnosed within the previous 10 years (except basal cell cancer that has been successfully removed); - breast cancer within the previous 20 years; - allergy to bisphosphonates; - previous treatment with an intravenous bisphosphonate at any time; - previous treatment with an oral bisphosphonate within the last 6 months, >1 month of treatment within the last year, or >3 months of treatment within the last 2 years.", "gender": "Female", "minimum_age": "55 Years", "maximum_age": "80 Years", "healthy_volunteers": "No", "id": "NCT00048061.xml"}